§ PHARMACEUTICALS
USD · PharmaceuticalsZVRA
ZEVRA THERAPEUTICS INC
USDSector · PharmaceuticalsBeta · 0.99
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
99 increased/new, 44 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/E | 12.4 | P/B | 3.26 |
| EPS (TTM) | 0.97 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BlackRock, Inc. | 4.5M | 0.0% | −1% |
| Woodline Partners LP | 3.5M | n/a | ±0% |
| Fidelity Management | 3.2M | 0.0% | +34% |
| Nantahala Capital Management, LLC | 2.5M | 0.9% | +42% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | n/a | n/a |
| State Street | 1.6M | 0.0% | +5% |
◇ AC INTELLIGENCE
Top institutional owners for ZVRA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER13.0% · 0 holders
OTHER49.8% · 95 holders
PASSIVE / INDEX12.4% · 8 holders
DEALER / BANK9.0% · 21 holders
QUALITY / COMPOUNDER8.0% · 9 holders
TACTICAL / MACRO3.5% · 3 holders
SYSTEMATIC / QUANT1.5% · 7 holders
ACTIVIST1.4% · 1 holder
INCOME / DEFENSIVE1.4% · 7 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ZVRA in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention ZVRA yet.